About

Home

Introduction

Statistics

Programs

Dignet

Gene

GenePair

BioSummarAI

Help & Docs

Documents

Help

FAQs

Links

Acknowledge

Disclaimer

Contact Us

Gene Information

Gene symbol: STT3A

Gene name: STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)

HGNC ID: 6172

Synonyms: TMC, MGC9042, STT3-A

Related Genes

#	Gene Symbol	Number of hits
1	MCC	1 hits

Related Sentences

#	PMID	Sentence
1	19733658	In this study, for the first time, TMC/MCC complex nanoparticles as a delivery system and as an adjuvant were developed and evaluated to obtain systemic and mucosal immune responses against nasally administered tetanus toxoid (TT).
2	19733658	The cellular viability was found to be higher with TMC/MCC complex compared to that of MCC and TMC alone.
3	19733658	Mice were nasally immunized with TT loaded TMC/MCC complex nanoparticles and compared to that of TMC and MCC nanoparticles.
4	19733658	TMC/MCC complex nanoparticles were shown to induce both the mucosal and systemic immune response indicating that this newly developed system has potential for mucosal administration of vaccines.
5	19733658	In this study, for the first time, TMC/MCC complex nanoparticles as a delivery system and as an adjuvant were developed and evaluated to obtain systemic and mucosal immune responses against nasally administered tetanus toxoid (TT).
6	19733658	The cellular viability was found to be higher with TMC/MCC complex compared to that of MCC and TMC alone.
7	19733658	Mice were nasally immunized with TT loaded TMC/MCC complex nanoparticles and compared to that of TMC and MCC nanoparticles.
8	19733658	TMC/MCC complex nanoparticles were shown to induce both the mucosal and systemic immune response indicating that this newly developed system has potential for mucosal administration of vaccines.
9	19733658	In this study, for the first time, TMC/MCC complex nanoparticles as a delivery system and as an adjuvant were developed and evaluated to obtain systemic and mucosal immune responses against nasally administered tetanus toxoid (TT).
10	19733658	The cellular viability was found to be higher with TMC/MCC complex compared to that of MCC and TMC alone.
11	19733658	Mice were nasally immunized with TT loaded TMC/MCC complex nanoparticles and compared to that of TMC and MCC nanoparticles.
12	19733658	TMC/MCC complex nanoparticles were shown to induce both the mucosal and systemic immune response indicating that this newly developed system has potential for mucosal administration of vaccines.
13	19733658	In this study, for the first time, TMC/MCC complex nanoparticles as a delivery system and as an adjuvant were developed and evaluated to obtain systemic and mucosal immune responses against nasally administered tetanus toxoid (TT).
14	19733658	The cellular viability was found to be higher with TMC/MCC complex compared to that of MCC and TMC alone.
15	19733658	Mice were nasally immunized with TT loaded TMC/MCC complex nanoparticles and compared to that of TMC and MCC nanoparticles.
16	19733658	TMC/MCC complex nanoparticles were shown to induce both the mucosal and systemic immune response indicating that this newly developed system has potential for mucosal administration of vaccines.